Form 8-K Anthera Pharmaceuticals For: Mar 07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Anthera Pharma (ANTH) Tops Q4 EPS by 10c
March 10, 2016 8:38 AM ESTAnthera Pharma (NASDAQ: ANTH) reported Q4 EPS of ($0.18), $0.10 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $1.92 million versus the consensus estimate of $150 thousand.
Cash and cash equivalents totaled $47 million as of December 31, 2015, compared to $2.6 million as of December 31,... More
